SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $781,433,310 | +62.8% | 3,683,400 | +47.7% | 0.39% | +66.9% |
| Q2 2023 | $480,021,222 | +300750.0% | 2,494,135 | +216.5% | 0.24% | +156.5% |
| Q1 2023 | $159,555 | +1512.0% | 788,041 | +923.1% | 0.09% | +1433.3% |
| Q4 2022 | $9,898 | -100.0% | 77,022 | -47.0% | 0.01% | -50.0% |
| Q3 2022 | $19,889,000 | -85.4% | 145,354 | -81.1% | 0.01% | -85.9% |
| Q2 2022 | $136,310,000 | +187.6% | 770,370 | +134.2% | 0.08% | +226.9% |
| Q1 2022 | $47,388,000 | +20.5% | 328,970 | +29.3% | 0.03% | +30.0% |
| Q4 2021 | $39,322,000 | +2.1% | 254,346 | +12.2% | 0.02% | -16.7% |
| Q3 2021 | $38,504,000 | -44.8% | 226,759 | -48.7% | 0.02% | -44.2% |
| Q2 2021 | $69,776,000 | -20.9% | 441,958 | -30.4% | 0.04% | -31.7% |
| Q1 2021 | $88,198,000 | +379.9% | 635,160 | +505.3% | 0.06% | +350.0% |
| Q4 2020 | $18,379,000 | – | 104,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |